Dementia News and Research

Latest Dementia News and Research

Reduction in alcohol prices increases alcohol-related mortality

Does a reduction in the price of alcohol result in an increase in deaths due to alcohol? This was the subject of a study following a significant reduction in taxes in Finland in 2004 (30% for spirits, 3% for wine).The abolition of import quotas by the EU in 2004 also made it possible to import from other member countries and this led to an increase of approximately 10% in alcohol consumption in Finland.

8 Apr 2011

SWHR roundtable to examine sex differences in Alzheimer's disease

At the Women's Health 2011: 19th Annual Conference plenary session, A Wake Up Call to Clinicians: Alzheimer's and Early Diagnosis, Geoffrey Beene Foundation President, Meryl Comer announced the Society for Women's Health Research's upcoming one-day Alzheimer's roundtable, exploring sex differences in this increasingly prevalent disease.

6 Apr 2011

High clusterin levels linked to Alzheimer's prevalence and severity

Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.

6 Apr 2011

MRIs can help predict MCI individuals at greatest risk for developing Alzheimer's disease

Using MRI, researchers may be able to predict which adults with mild cognitive impairment are more likely to progress to Alzheimer's disease, according to the results of a study published online and in the June issue of Radiology.

6 Apr 2011

Major depression linked to premature aging of immune cells: Study

Certain cases of major depression are associated with premature aging of immune cells, which may make people more susceptible to other serious illness, according to findings from a new UCSF-led study.

6 Apr 2011

Physical activity may moderate impact of stress on telomeres

UCSF scientists are reporting several studies showing that psychological stress leads to shorter telomeres - the protective caps on the ends of chromosomes that are a measure of cell age and, thus, health. The findings also suggest that exercise may prevent this damage.

5 Apr 2011

Researchers to develop future body sensor network

Modern man is surrounded by a multitude of sensors. Today's sensors are simple and made for specific purposes, like measuring temperature, balance, build-up of smoke, or tyre pressure. The common trait of the sensors is that they are all embedded in a closed system.

5 Apr 2011

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.

5 Apr 2011

New insight into Parkinson's disease

As Parkinson's Awareness Month gets underway, a Canadian-led international study is providing important new insight into Parkinson's disease and paving the way for new avenues for clinical trials.

5 Apr 2011

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.

5 Apr 2011

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.

4 Apr 2011

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.

4 Apr 2011

Scientists identify five new genes that increase risk of developing Alzheimer's

A leading UK scientist's search for factors that increase the risk of developing Alzheimer's has uncovered five new genes to help pinpoint what's going wrong in the brain.

4 Apr 2011

Researchers identify four new genes linked to Alzheimer's disease

In the largest study of its kind, researchers from a consortium of 44 universities and research institutions in the United States, including Rush University Medical Center, identified four new genes linked to Alzheimer's disease. Each gene individually adds to the risk of having this common form of dementia later in life.

4 Apr 2011

Discovery of 4 new genes associated with Alzheimer's

In the largest study of its kind, researchers from a consortium led by the University of Pennsylvania School of Medicine, Boston University School of Medicine and the University of Miami identified four new genes linked to Alzheimer's disease. Each gene individually adds to the risk of having this common form of dementia later in life. These new genes offer a portal into what causes Alzheimer's disease and is a major advance in the field.

3 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta - the primary constituent of the plaques found in the brains of Alzheimer's disease patients - also had changes in brain structure similar to those seen in Alzheimer's patients.

31 Mar 2011

Dementia News and Research

Latest Dementia News and Research

Reduction in alcohol prices increases alcohol-related mortality

SWHR roundtable to examine sex differences in Alzheimer's disease

High clusterin levels linked to Alzheimer's prevalence and severity

MRIs can help predict MCI individuals at greatest risk for developing Alzheimer's disease

Major depression linked to premature aging of immune cells: Study

Physical activity may moderate impact of stress on telomeres

Researchers to develop future body sensor network

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

New insight into Parkinson's disease

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Scientists identify five new genes that increase risk of developing Alzheimer's

Researchers identify four new genes linked to Alzheimer's disease

Discovery of 4 new genes associated with Alzheimer's

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

New research to examine links between aluminium and Alzheimer's disease

Atypical antipsychotics is a safe mental health medication for nursing home residents

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Dementia News and Research

Latest Dementia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in